首页> 外文OA文献 >High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

【2h】

High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

机译：高度抗化疗的原发性卵巢癌细胞株过度表达人滋养层细胞表面标志物（Trop-2），并且对人源化抗Trop-2单克隆抗体hRS7的免疫疗法高度敏感

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2 antibody, as a therapeutic agent against chemotherapy-resistant ovarian disease.

机译：我们评估了人类滋养细胞细胞表面标志物（Trop-2）的表达以及人源化单克隆抗Trop-2抗体hRS7作为抗化疗药性卵巢疾病的治疗剂的潜力。

著录项

作者
Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Bellone, Marta; Todeschini, Paola; Carrara, Luisa; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Santin, Alessandro D;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. [J] . Varughese J, Cocco E, Bellone S, Gynecologic Oncology: An International Journal . 2011,第1期

机译：高度抗化疗的原发性卵巢癌细胞株高表达人滋养层细胞表面标志物（Trop-2），并且对人源化单克隆抗Trop-2抗体hRS7的免疫疗法高度敏感。
2. Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody [J] . American Journal of Obstetrics and Gynecology . 2011,第6期

机译：宫颈癌过表达人滋养层细胞表面标记（Trop-2），并且对人源化抗Trop-2单克隆抗体hRS7的免疫疗法高度敏感
3. Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody. [J] . Varughese J, Cocco E, Bellone S, Cancer: A Journal of the American Cancer Society . 2011,第14期

机译：子宫浆液性乳头状癌过表达人类滋养细胞表面标志物（Trop-2），并且对人源化抗Trop-2单克隆抗体hRS7的免疫疗法高度敏感。
4. High-grade chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7 a humanized monoclonal anti-Trop-2 antibody [O] . Joyce Varughese, Emiliano Cocco, Stefania Bellone, -1

机译：高档化疗耐药初级卵巢癌细胞系过表达人滋养细胞 - 表面标记物（Troph-2）对HRS7的免疫疗法高度敏感人源化单克隆抗TOP-2抗体
5. Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody [O] . Varughese, Joyce, Cocco, Emiliano, Bellone, Stefania, 2012

机译：宫颈癌过表达人类滋养细胞细胞表面标记（Trop-2），并且对人源化抗Trop-2单克隆抗体hRS7的免疫疗法高度敏感

High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

摘要

著录项

相似文献

相关主题

期刊订阅